These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 30929527)

  • 1. Application and design of esterase-responsive nanoparticles for cancer therapy.
    Dong H; Pang L; Cong H; Shen Y; Yu B
    Drug Deliv; 2019 Dec; 26(1):416-432. PubMed ID: 30929527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Smart Dual-Stimuli Responsive Nanoparticles for Controlled Anti-Tumor Drug Release and Cancer Therapy.
    Wu F; Qiu F; Wai-Keong SA; Diao Y
    Anticancer Agents Med Chem; 2021; 21(10):1202-1215. PubMed ID: 32972353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous Enzyme-responsive Nanoplatforms for Anti-tumor Therapy.
    Lou XF; Du YZ; Xu XL
    Curr Drug Targets; 2021; 22(8):845-855. PubMed ID: 33459230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
    Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
    Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-Specific Membrane Antigen and Esterase Dual Responsive Camptothecin-Oligopeptide Self-Assembled Nanoparticles for Efficient Anticancer Drug Delivery.
    Xu B; Yan M; Zhou F; Cai D; Guo W; Jia X; Liu R; Ma T; Li T; Gao F; Wang P; Lei H
    Int J Nanomedicine; 2021; 16():7959-7974. PubMed ID: 34887660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle therapeutics: Technologies and methods for overcoming cancer.
    Cerqueira BB; Lasham A; Shelling AN; Al-Kassas R
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):140-51. PubMed ID: 26515260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.
    Baeza A; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimuli-responsive nanoscale drug delivery systems for cancer therapy.
    Li L; Yang WW; Xu DG
    J Drug Target; 2019 Apr; 27(4):423-433. PubMed ID: 30173577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies To Design and Synthesize Polymer-Based Stimuli-Responsive Drug-Delivery Nanosystems.
    Qin X; Li Y
    Chembiochem; 2020 May; 21(9):1236-1253. PubMed ID: 31889379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual disassembly and biological evaluation of enzyme/oxidation-responsive polyester-based nanoparticulates for tumor-targeting delivery.
    Hong SH; Larocque K; Jaunky DB; Piekny A; Oh JK
    Colloids Surf B Biointerfaces; 2018 Dec; 172():608-617. PubMed ID: 30223243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-Based Nanoparticles with Stimuli-Responsive for Anti-Tumor Therapy.
    Yang L; Zhang K; Zheng D; Bai Y; Yue D; Wu L; Ling H; Ni S; Zou H; Ye B; Liu C; Deng Y; Liu Q; Li Y; Wang D
    Int J Nanomedicine; 2023; 18():6293-6309. PubMed ID: 37954456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The development of novel tumor targeting delivery strategy].
    Gao HL; Jiang XG
    Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery.
    Fernando IR; Ferris DP; Frasconi M; Malin D; Strekalova E; Yilmaz MD; Ambrogio MW; Algaradah MM; Hong MP; Chen X; Nassar MS; Botros YY; Cryns VL; Stoddart JF
    Nanoscale; 2015 Apr; 7(16):7178-83. PubMed ID: 25820516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational Design of Multi-Stimuli-Responsive Nanoparticles for Precise Cancer Therapy.
    An X; Zhu A; Luo H; Ke H; Chen H; Zhao Y
    ACS Nano; 2016 Jun; 10(6):5947-58. PubMed ID: 27285378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering Nanorobots for Tumor-Targeting Drug Delivery: From Dynamic Control to Stimuli-Responsive Strategy.
    Huang L; Chen F; Lai Y; Xu Z; Yu H
    Chembiochem; 2021 Dec; 22(24):3369-3380. PubMed ID: 34411411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment.
    Zou T; Lu W; Mezhuev Y; Lan M; Li L; Liu F; Cai T; Wu X; Cai Y
    Eur J Pharm Biopharm; 2021 Sep; 166():30-43. PubMed ID: 34098073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esterase-Responsive Polypeptide Vesicles as Fast-Response and Sustained-Release Nanocompartments for Fibroblast-Exempt Drug Delivery.
    Duan W; Ji S; Guan Y; Mu X; Fang S; Lu Y; Zhou X; Sun J; Li Z
    Biomacromolecules; 2020 Dec; 21(12):5093-5103. PubMed ID: 33151670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer-based ATP-responsive delivery systems for cancer diagnosis and treatment.
    Sameiyan E; Bagheri E; Dehghani S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Acta Biomater; 2021 Mar; 123():110-122. PubMed ID: 33453405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.